Catalyst Pharmaceutical
CPRX
CPRX
359 hedge funds and large institutions have $2.04B invested in Catalyst Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 129 increasing their positions, 133 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 363 → 359 (-4)
7% less capital invested
Capital invested by funds: $2.2B → $2.04B (-$163M)
55% less call options, than puts
Call options by funds: $4M | Put options by funds: $8.84M
Holders
359
Holding in Top 10
3
Calls
$4M
Puts
$8.84M
Top Buyers
| 1 | +$43.1M | |
| 2 | +$19.1M | |
| 3 | +$15.8M | |
| 4 |
Millennium Management
New York
|
+$15.4M |
| 5 |
Fundsmith LLP
London,
United Kingdom
|
+$13.5M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$27.6M | |
| 3 | -$14.1M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$9.13M |
| 5 |
O
OrbiMed
New York
|
-$9.05M |